Display options
Cite
Glover M, Soni S, Ren Q, et al. Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens. Oncol Lett. 2017;14(4):3927-3934doi: 10.3892/ol.2017.6668.
Glover, M., Soni, S., Ren, Q., Maclennan, G. T., Fu, P., & Gupta, S. (2017). Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens. Oncology letters, 14(4), 3927-3934. https://doi.org/10.3892/ol.2017.6668
Glover, Michael, et al. "Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens." Oncology letters vol. 14,4 (2017): 3927-3934. doi: https://doi.org/10.3892/ol.2017.6668
Glover M, Soni S, Ren Q, Maclennan GT, Fu P, Gupta S. Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens. Oncol Lett. 2017 Oct;14(4):3927-3934. doi: 10.3892/ol.2017.6668. Epub 2017 Jul 26. PMID: 28943900; PMCID: PMC5604163.
Copy Download .nbib Format: NLM
Share it on

Oncol Lett. 2017 Oct;14(4):3927-3934. doi: 10.3892/ol.2017.6668. Epub 2017 Jul 26.

Influence of chronic inflammation on Bcl-2 and PCNA expression in prostate needle biopsy specimens.

Oncology letters

Michael Glover, Shardul Soni, Qinghu Ren, Gregory T Maclennan, Pingfu Fu, Sanjay Gupta

Affiliations

  1. Department of Urology, Case Western Reserve University, Cleveland, OH 44106, USA.
  2. Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA.
  3. Division of General Medical Sciences, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH 44106, USA.
  4. Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, OH 44106, USA.
  5. The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
  6. Department of Urology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106, USA.

PMID: 28943900 PMCID: PMC5604163 DOI: 10.3892/ol.2017.6668

Abstract

The association between inflammation and cancer has been established in certain forms of human malignancies; however, its role in prostate cancer remains unclear. The present study investigates a possible association between chronic inflammation and the development of epithelial neoplasia in the prostate. Needle biopsy specimens were obtained from patients with serum prostate-specific antigen levels >4 ng/ml, evaluated for morphological findings, and immunostained for Bcl-2 and proliferating cell nuclear antigen (PCNA). Bcl-2 is a survival protein that appears to lie at a nodal point in pathways involved in cell survival, carcinogenesis, and development of therapeutic resistance in certain cancer types. Similarly, PCNA is a critical protein for DNA replication, repair of DNA damage, chromatin structure maintenance, chromosome segregation and cell-cycle progression. The association between these two proteins was examined in prostate tissues with and without chronic inflammation, as well as tissues with and without evidence of neoplastic changes. Of the 106 needle biopsies examined, 18% exhibited atrophy with inflammation. Proliferative inflammatory atrophy/post-atrophic hyperplasia were observed in 42%, high-grade prostatic intraepithelial neoplasia (HGPIN) in 8%, prostatic adenocarcinoma in 11%, and 2% had atypical acinar proliferation suspicious for malignancy. A total of 36 specimens were stained for Bcl-2 and PCNA. Bcl-2 was expressed widely in inflammatory and epithelial tissue; however, more intense expression was observed in the areas of chronic inflammation, predominantly in infiltrating immune cells. The highest proliferation index was observed in the epithelia of HGPIN and cancer. An inverse correlation between the expression of Bcl-2 and the expression of PCNA was observed in the epithelium. The areas of chronic inflammation were associated with increased Bcl-2 expression, whereas the highly proliferative epithelium minimally expressed Bcl-2. These results suggest that Bcl-2 alters the phenotype of particular epithelial cells with a gain in neoplastic characteristics, leading to a likely precursor that may later progress into HGPIN and cancer.

Keywords: chronic inflammation; needle biopsy; post atrophic hyperplasia; proliferative inflammatory atrophy; prostate cancer; prostate-specific antigen

References

  1. Prostate. 2016 Nov;76(15):1399-408 - PubMed
  2. Eur J Cancer. 2010 Sep;46(14):2555-62 - PubMed
  3. Mol Cancer Res. 2006 Jan;4(1):1-8 - PubMed
  4. Prostate Cancer Prostatic Dis. 2015 Sep;18(3):264-9 - PubMed
  5. BJU Int. 2014 Aug;114(2):168-76 - PubMed
  6. Arch Ital Urol Androl. 2014 Sep 30;86(3):208-11 - PubMed
  7. Prostate Cancer Prostatic Dis. 2016 Sep;19(3):305-10 - PubMed
  8. Semin Oncol. 2013 Jun;40(3):244-58 - PubMed
  9. Mutat Res. 2008 Jul-Aug;659(1-2):15-30 - PubMed
  10. Prostate. 2004 Sep 15;61(1):60-72 - PubMed
  11. Inflamm Res. 2015 May;64(5):275-86 - PubMed
  12. Neoplasia. 2004 Jul-Aug;6(4):390-400 - PubMed
  13. Prostate. 2015 Oct;75(14):1669-75 - PubMed
  14. Future Oncol. 2008 Oct;4(5):637-45 - PubMed
  15. Ann N Y Acad Sci. 2010 Aug;1203:1-6 - PubMed
  16. Cent European J Urol. 2013;66(3):256-62 - PubMed
  17. Adv Exp Med Biol. 2014;816:153-81 - PubMed
  18. Eur J Cancer. 2013 Dec;49(18):3821-30 - PubMed
  19. Int J Cancer. 1996 Aug 22;69(4):295-300 - PubMed
  20. Ann Bot. 2011 May;107(7):1127-40 - PubMed
  21. Int J Oncol. 2012 Dec;41(6):1950-8 - PubMed
  22. Adv Cancer Res. 2015;128:173-96 - PubMed
  23. Histopathology. 2012 Jan;60(1):4-27 - PubMed
  24. Urology. 2005 Apr;65(4):745-9 - PubMed
  25. Crit Rev Clin Lab Sci. 2007;44(3):243-70 - PubMed
  26. PLoS One. 2012;7(5):e37045 - PubMed
  27. BJU Int. 2014 Jun;113(6):986-92 - PubMed
  28. Cell Death Differ. 2011 Sep;18(9):1414-24 - PubMed
  29. Am J Pathol. 1999 Dec;155(6):1985-92 - PubMed
  30. Mol Carcinog. 2014 Jan;53(1):8-18 - PubMed
  31. Andrologia. 2008 Apr;40(2):134-7 - PubMed
  32. J Urol. 2002 May;167(5):2267-70 - PubMed
  33. PLoS One. 2010 Jan 15;5(1):e8736 - PubMed
  34. Recent Results Cancer Res. 2014;202:27-37 - PubMed
  35. Prostate. 2009 Sep 15;69(13):1378-86 - PubMed
  36. Ann N Y Acad Sci. 2009 Feb;1155:206-21 - PubMed
  37. Front Pharmacol. 2014 Jul 16;5:170 - PubMed
  38. Prostate Cancer Prostatic Dis. 2016 Jun;19(2):145-50 - PubMed
  39. J Urol. 2006 Sep;176(3):1012-6 - PubMed
  40. Histopathology. 2012 Jan;60(1):87-117 - PubMed
  41. Urol Oncol. 2014 Nov;32(8):1101-7 - PubMed
  42. Prostate. 2016 Feb;76(2):199-206 - PubMed

Publication Types

Grant support